4.7 Editorial Material

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?

期刊

CLINICAL MICROBIOLOGY AND INFECTION
卷 24, 期 6, 页码 570-572

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.cmi.2018.01.003

关键词

Biofilm; Resistance; Standardized methods; Susceptibility testing; Tolerance

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Veterinary Sciences

Characterization of pig skin microbiome and appraisal as an in vivo subcutaneous injection model

Sofia Wareham-Mathiassen, Vera Pinto Glenting, Lene Bay, Marie Allesen-Holm, Henrik Bengtsson, Thomas Bjarnsholt

Summary: The microflora of pig neck skin is similar to that of human skin, although there are some differences at the species level. Pig neck skin can be used as an injection model, but there are certain limitations.

LABORATORY ANIMALS (2023)

Article Microbiology

Adaptation of Pseudomonas aeruginosa biofilms to tobramycin and the quorum sensing inhibitor C-30 during experimental evolution requires multiple genotypic and phenotypic changes

Mona Bove, Mette Kolpen, Mads Lichtenberg, Thomas Bjarnsholt, Tom Coenye

Summary: In this study, the fitness, antimicrobial susceptibility, metabolic activity, gene expression, in vitro production of virulence factors and in vivo virulence of experimentally evolved Pseudomonas aeruginosa PAO1 were evaluated. Mutations in mexT and fusA1 were found in the evolved strains, leading to altered fitness, metabolic activity, mexE expression, and antimicrobial susceptibility. However, the in vitro production of virulence factors and virulence in vivo were unchanged compared to the wild-type strains. These evolved strains also showed reduced susceptibility to tobramycin in an in vivo mouse model. Overall, this study highlights the impact of experimental evolution on the fitness and antimicrobial susceptibility of Pseudomonas aeruginosa.

MICROBIOLOGY-SGM (2023)

Article Multidisciplinary Sciences

3D blood-brain barrier-organoids as a model for Lyme neuroborreliosis highlighting genospecies dependent organotropism

Yvonne Adams, Anne Skovsbo Clausen, Peter Ostrup Jensen, Malin Lager, Peter Wilhelmsson, Anna J. Henningson, Per-Eric Lindgren, Daniel Faurholt-Jepsen, Helene Mens, Peter Kraiczy, Kasper Norskov Kragh, Thomas Bjarnsholt, Andreas Kjaer, Anne-Mette Lebech, Anja R. Jensen

Summary: We screened a group of low-passage Borrelia burgdorferi s.l. isolates using a novel human-derived 3D blood-brain barrier (BBB)-organoid model. The results showed that human-derived BBB-organoids can be invaded by Borrelia spirochetes, leading to swelling and loss of structural integrity. The BBB-organoid model highlights the tropism between B. burgdorferi s.l. genospecies and their ability to cross the blood-brain barrier, contributing to central nervous system infection.

ISCIENCE (2023)

Article Dermatology

Reduced Skin Microbiome Diversity in Infancy Is Associated with Increased Risk of Atopic Dermatitis in High-Risk Children

Anne -Sofie Halling, Blaine Gabriel Fritz, Trine Gerner, Maria Rasmussen Rinnov, Lene Bay, Mette Hjorslev Knudgaard, Nina Haarup Ravn, Simon Trautner, Iben Frier Ruge, Caroline Olesen, Isabel Diiaz-Pinees Cort, Lone Skov, Nikolaj Sorensen, Amalie Thorsti Moller Ronnstad, Simon F. Thomsen, Alexander Egeberg, Ivone Jakasa, Sanja Kezic, Thomas Bjarnsholt, Jacob P. Thyssen

Summary: This study examined the association between alterations in the skin microbiome and the risk of atopic dermatitis (AD) in a Danish birth cohort. While no overall association was found, the study showed that lower alpha diversity in the skin microbiome at 2 months of age was associated with an increased risk of AD, particularly in children with parents who have atopy.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2023)

Article Medicine, General & Internal

Defining the temporal relationship between the skin microbiome, immune response and skin barrier function during flare and resolution of atopic dermatitis: protocol of a Danish intervention study

Amalie Thorsti Moller Ronnstad, Lene Bay, Iben Frier Ruge, Anne-Sofie Halling, Blaine Gabriel Fritz, Ivone Jakasa, Rosalie Luiten, Sanja Kezic, Simon Francis Thomsen, Thomas Bjarnsholt, Jacob P. Thyssen

Summary: This study aims to investigate the changes in the skin microbiome, skin barrier, and immune response in patients with AD, as well as the temporal relationship between them. The study includes 81 AD patients and 41 matched controls, and collects skin biopsies, tape strips, skin and nasal swabs for analysis using RNA sequencing, multiplex immunoassays, liquid chromatography-mass spectrometry, and 16S rDNA analysis. The findings will be presented at national and international conferences and published in international peer-reviewed publications.

BMJ OPEN (2023)

Article Biochemical Research Methods

Protocol to assess metabolic activity of Pseudomonas aeruginosa by measuring heat flow using isothermal calorimetry

Katrin Beilharz, Kasper Norskov Kragh, Blaine Fritz, Julius B. Kirkegaard, Tim Tolker-Nielsen, Thomas Bjarnsholt, Mads Lichtenberg

Summary: This protocol presents a method for assessing the metabolic activity of bacterial populations using isothermal calorimetry. It includes steps for preparing different growth models of Pseudomonas aeruginosa and performing continuous metabolic activity measurements. The protocol also uses principal component analysis and probabilistic logistic classification to differentiate between metabolic states of different populations and assess resemblance to wild-type bacteria. This fine-scale metabolic measurement method can contribute to the understanding of microbial physiology.

STAR PROTOCOLS (2023)

Article Microbiology

Effect of malate on the activity of ciprofloxacin against Pseudomonas aeruginosa in different in vivo and in vivo-like infection models

Xuerui Bao, Ellen Goeteyn, Aurelie Crabbe, Tom Coenye

Summary: D,L-malate enhances ciprofloxacin activity against P. aeruginosa, improving antibiotic therapy in infection environments. The choice of model system influences the outcome of the experiment, emphasizing the importance of using models that closely mimic the in vivo environment. This study confirms the potential of D,L-malate to enhance ciprofloxacin activity against P. aeruginosa-associated infections.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2023)

Article Microbiology

A simplified bacterial community found within the epidermis than at the epidermal surface of atopic dermatitis patients and healthy controls

Christopher J. Barnes, Maria Asplund, Maja-Lisa Clausen, Linett Rasmussen, Caroline Meyer Olesen, Yasemin Topal Yuksel, Paal Skytt Andersen, Thomas Litman, Kim Holmstrom, Lene Bay, Blaine Gabriel Fritz, Thomas Bjarnsholt, Tove Agner, Anders Johannes Hansen

Summary: Considerable research has been done on understanding the healthy skin microbiome and the role of specific microbes in skin disorders. This study used sampling techniques to investigate the bacterial communities on the epidermal surface and within the stratum corneum of atopic dermatitis patients and healthy controls. The results showed variations in bacterial richness at different layers of the skin, suggesting that sampling strategies can be tailored based on the research hypothesis. It was also observed that significant community variation between atopic dermatitis patients and healthy controls was only observable at the epidermal surface, but individual taxa consistently differed with atopic dermatitis status throughout the entire epidermis.

BMC MICROBIOLOGY (2023)

Article Infectious Diseases

Biofilm formation on endovascular aneurysm repair (EVAR) grafts-a proof of concept in vitro model

Torgny Sunnerhagen, Franziska Schwartz, Lars Christophersen, Thomas Bjarnsholt, Klaus Qvortrup, Nikolaj Eldrup, Katja Vogt, Claus Moser

Summary: This study examines whether Pseudomonas aeruginosa and Staphylococcus aureus form biofilm on EVAR prostheses. The results show that bacteria can rapidly adhere to and form antibiotic-tolerant biofilms on EVAR graft material.

CLINICAL MICROBIOLOGY AND INFECTION (2023)

Review Microbiology

Biofilm antimicrobial susceptibility testing: where are we and where could we be going?

Tom Coenye

Summary: Our understanding of biofilm biology has greatly increased, but it has not yet resulted in major changes in clinical practice. The lack of standardized tools for studying biofilms in the clinical microbiology laboratory, particularly in antimicrobial susceptibility testing (AST), is a major obstacle. Biofilm lifestyle significantly impacts antibiotic susceptibility, but AST is still typically conducted using planktonic cells. This review aims to provide an overview of the current state of biofilm AST, highlight knowledge gaps, discuss potential ways to improve AST, and address the bottlenecks preventing its use in clinical practice.

CLINICAL MICROBIOLOGY REVIEWS (2023)

Review Infectious Diseases

A systematic review of the use of bacteriophages for in vitro biofilm control

Luciana Meneses, Ana Catarina Brandao, Tom Coenye, Ana Cristina Braga, Diana Priscila Pires, Joana Azeredo

Summary: This systematic review summarizes and analyzes the published data on the use of bacteriophages to control pre-formed biofilms in vitro, providing recommendations for future experiments. The findings suggest that phage concentration, burst size, and latent period can influence the efficacy of biofilm control, with higher concentrations and specific characteristics leading to better outcomes.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2023)

Article Microbiology

High throughput determination of the biofilm prevention concentration for Pseudomonas aeruginosa biofilms using a synthetic cystic fibrosis sputum medium

Amber De Bleeckere, Sara Van den Bossche, Pieter-Jan De Sutter, Tine Beirens, Aurelie Crabbe, Tom Coenye

Summary: In this study, a high throughput method was developed to determine the antimicrobial concentration required to prevent Pseudomonas aeruginosa biofilm formation using a synthetic cystic fibrosis sputum medium (SCFM2). Significant differences were observed between biofilm preventing concentrations (BPCs) and minimal inhibitory concentrations (MICs) of three antibiotics, with the BPCs consistently higher than the MICs. This high throughput assay could be a valuable addition to evaluate the antimicrobial susceptibility in P. aeruginosa biofilms in the context of cystic fibrosis (CF).

BIOFILM (2023)

Article Microbiology

Microbial Primer: In vivo biofilm

Kendra P. Rumbaugh, Thomas Bjarnsholt

Summary: This article traces the historical development of biofilms and their significance in infections, discusses the importance and challenges of in vivo biofilm research, and summarizes the current understanding and knowledge gaps in biofilm infections.

MICROBIOLOGY-SGM (2023)

Review Microbiology

What's in a name? Characteristics of clinical biofilms

Mads Lichtenberg, Tom Coenye, Matthew R. Parsek, Thomas Bjarnsholt, Tim Holm Jakobsen

Summary: In vitro biofilms are distinct microbial communities characterized by physical traits, phenotypic features, and antibiotic tolerance. The importance of these traits varies depending on the environment and bacterial species. Mechanisms enabling antibiotic resistance in biofilms include physical barriers, physiological adaptations, and changes in gene expression. However, there is little consensus on gene expression profiles in biofilms, and a definitive "biofilm signature transcriptome" has not been identified. Spatial and temporal variability in biofilms greatly differs across systems or environments. Clinical biofilms may differ from those cultivated in laboratories and found in the environment, emphasizing the need for a better understanding of their characteristics.

FEMS MICROBIOLOGY REVIEWS (2023)

暂无数据